USPTO Examiner JANG JAEICK - Art Unit 3785

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19021269MASSAGERJanuary 2025March 2025Allow200YesNo
18731633SYSTEM AND METHOD FOR A HYPERBARIC CHAMBER HAVING MIRRORED CONTROLSJune 2024February 2025Allow910NoNo
18604209DEVICES AND METHODS FOR USING MEDICAMENT DEVICESMarch 2024August 2024Allow510NoNo
18130254INHALATION DEVICE WITH CYLINDRICAL ROTATABLE DIAL FOR INPUT OF A TARGET AMOUNT OF INHALED SUBSTANCEApril 2023March 2025Abandon2320NoNo
17831002Chest Compression Assist GloveJune 2022June 2025Allow3600YesNo
17754613PROCTECTIVE HOOD FOR MEDICAL USEApril 2022May 2025Allow3710YesNo
17639827CONTROL BOX AND MASSAGE WATER POOLMarch 2022April 2025Allow3700YesNo
17570462Joint Cracking DeviceJanuary 2022December 2024Abandon3510NoNo
17457455SYSTEM FOR VENTILATION OF A BEINGDecember 2021March 2025Allow3920YesNo
17612322MASKNovember 2021March 2025Abandon4010NoNo
17521751Vibrating and Heating Massage VestNovember 2021December 2024Allow3710NoNo
17594989METHOD AND APPARATUS FOR SIMULTANEOUSLY ADMINISTERING OXYGEN, AND METERED DOSE INHALER MEDICATION BY INHALATIONNovember 2021February 2025Allow3910YesNo
17507722CALF STRETCHING APPARATUSOctober 2021March 2025Allow4000YesNo
17602552RESPIRATORY PRESSURE THERAPY SYSTEMOctober 2021March 2025Allow4110YesNo
17601543SYSTEM, METHOD AND APPARATUS FOR DYNAMIC OXYGEN CONSERVER WITH INHALATION SENSOROctober 2021June 2025Abandon4420YesNo
17434369HEADGEAR FOR A PATIENT INTERFACEAugust 2021January 2025Allow4110YesNo
17407001VENTILATOR FOR HIGH-FLOW OXYGEN THERAPYAugust 2021March 2025Allow4320YesNo
17430145TEXTILE TUBE FOR A THERAPY DEVICEAugust 2021September 2024Allow3801YesNo
17358227POWERED AIR-PURIFYING RESPIRATOR CARRIAGE AND ASSEMBLYJune 2021December 2024Allow4210YesNo
17349893NEBULIZERJune 2021May 2024Allow3500YesNo
17414845Overhead ExoskeletonJune 2021January 2025Allow4330NoNo
17414594Neck Switch Device in a Passive ExoskeletonJune 2021July 2024Allow3710NoNo
17414840Device for Compensating a Shoulder Elevation in a Passive ExoskeletonJune 2021April 2025Abandon4630NoNo
17312777AIR TREATMENT APPARATUSJune 2021December 2024Allow4220YesNo
17337718ENERGY CONCENTRATION APPARATUS HAVING CENTRAL HOLE AND MICRO-SLITJune 2021October 2024Allow4110NoNo
17335331Systems, methods, and apparatus for a beauty product that can alternatively use RF, ultra red and medical LED light for the purposes of healing acne and growing hair on the scalpJune 2021October 2024Abandon4110NoNo
17298759SPEAKING VALVE PROTECTORJune 2021November 2024Abandon4110NoNo
17298170RESPIRATORY MONITOR DEVICE AND RESPIRATORY MONITORING SYSTEMMay 2021April 2025Allow4630YesNo
17297926LOWER JAW AND TONGUE THRUSTING, ENDOTRACHEAL TUBE AND FLEXIBLE FIBEROPTIC ENDOSCOPE INTUBATION ORAL AIRWAY DEVICEMay 2021September 2024Allow4010YesNo
17296288DEVICE FOR CONNECTING A LEG OF A PERSON TO A MOVEMENT MECHANISMMay 2021April 2025Abandon4720NoNo
17293171Humidity Nasal Prong Cannula AssemblyMay 2021November 2024Abandon4210NoNo
17316025MASSAGE GUN WITH IMPROVED CONNECTING CABLEMay 2021December 2023Allow3120YesNo
17309189BREATHING ASSISTANCE APPARATUSMay 2021December 2024Allow4320YesNo
17306720MEDICAL DEVICE RESPIRATORMay 2021February 2025Abandon4530NoNo
17245534MASK APPARATUS AND METHOD FOR CONTROLLING THE SAMEApril 2021July 2024Allow3910NoNo
17241072BREATHING GUIDE APPARATUS AND MASK SYSTEM INCLUDING THE SAMEApril 2021October 2024Abandon4210NoNo
17288313RELAY ADMINISTRATION DEVICE AND NITRIC OXIDE ADMINISTRATION SYSTEMApril 2021December 2024Abandon4420NoNo
17281676DELIVERY OF LOW SURFACE TENSION COMPOSITIONS TO THE PULMONARY SYSTEM VIA ELECTRONIC BREATH ACTUATED DROPLET DELIVERY DEVICEMarch 2021June 2025Abandon5020NoNo
17214837SYSTEM AND METHOD FOR DYNAMICALLY REDUCING MICROBIOLOGICAL CONTAMINANTS IN THE VICINITY OF PERSONAL EQUIPMENTMarch 2021October 2024Allow4320YesNo
17210115RESPIRATORY PROTECTION SYSTEM FOR SURGERYMarch 2021September 2024Allow4220YesNo
17206629Nonwoven Filtration MediaMarch 2021August 2024Abandon4101NoNo
17273203MEDICAMENT DELIVERY DEVICEMarch 2021April 2024Allow3810YesNo
17269639CANNABINOID-CONTAINING PRODUCTS, CONTAINERS, SYSTEMS, AND METHODSFebruary 2021August 2024Abandon4201NoNo
17263579HEADBAND ASSEMBLY AND MASK SYSTEMJanuary 2021May 2025Allow5260YesNo
17159342VENTILATOR-WEANING TIMING PREDICTION SYSTEM, PROGRAM PRODUCT THEREOF AND METHOD FOR BUILDING AND USING THE SAMEJanuary 2021July 2024Allow4220NoNo
17146038CATHETER INFLATABLE CUFF PRESSURE STABILIZERJanuary 2021June 2024Abandon4110NoNo
17248091FACE MASK WITH CENTRAL FLAPJanuary 2021May 2024Abandon4010NoNo
17130423RESPIRATORY THERAPY APPARATUS CONTROLDecember 2020February 2024Allow3810NoNo
17103474Filtered Air Supply AssemblyNovember 2020October 2024Abandon4620NoNo
17250055VENTILATION PATTERN FOR HEMODYNAMIC PARAMETER DETERMINATION DURING MECHANICAL VENTILATIONNovember 2020May 2024Allow4220NoNo
17096840METHODS FOR CONTROLLING MECHANICAL LUNG VENTILATIONNovember 2020March 2024Allow4010YesNo
17090072HUFF COUGH SIMULATION DEVICENovember 2020January 2024Allow3810NoNo
16945019ENDOTRACHEAL TUBE EXTUBATION DETECTIONJuly 2020January 2024Allow4210YesNo
16887667Disinfecting Methods and ApparatusMay 2020June 2024Allow4810YesNo

Appeals Overview

No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.

Examiner JANG, JAEICK - Prosecution Strategy Guide

Executive Summary

Examiner JANG, JAEICK works in Art Unit 3785 and has examined 51 patent applications in our dataset. With an allowance rate of 64.7%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 41 months.

Allowance Patterns

Examiner JANG, JAEICK's allowance rate of 64.7% places them in the 18% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by JANG, JAEICK receive 1.41 office actions before reaching final disposition. This places the examiner in the 31% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by JANG, JAEICK is 41 months. This places the examiner in the 7% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +61.4% benefit to allowance rate for applications examined by JANG, JAEICK. This interview benefit is in the 98% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 45.0% of applications are subsequently allowed. This success rate is in the 96% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 15.4% of cases where such amendments are filed. This entry rate is in the 10% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Petition Practice

When applicants file petitions regarding this examiner's actions, 66.7% are granted (fully or in part). This grant rate is in the 85% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 43% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 6.1% of allowed cases (in the 81% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • RCEs are effective: This examiner has a high allowance rate after RCE compared to others. If you receive a final rejection and have substantive amendments or arguments, an RCE is likely to be successful.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.